Medprin Regenerative Medical Technologies Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 145.78 million compared to CNY 139.25 million a year ago. Revenue was CNY 145.78 million compared to CNY 139.25 million a year ago.

Net income was CNY 25.42 million compared to CNY 30.03 million a year ago. Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.45 a year ago. Diluted earnings per share from continuing operations was CNY 0.38 compared to CNY 0.45 a year ago.